Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Cadila Healthcare arm gets USFDA nod for Haloperidol Decanoate injection to treat schizophrenia

      Cadila Healthcare arm gets USFDA nod for Haloperidol Decanoate injection to treat schizophrenia

      Medical Dialogues Bureau25 Oct 2019 11:32 AM IST
      Haloperidol is used in the treatment of schizophrenia and for the control of tics and vocal utterances of Tourette syndrome, Cadila Healthcare...
      Major US retailers including Walmart pull bottles of JnJ baby powder from shelves

      Major US retailers including Walmart pull bottles of JnJ baby powder from shelves

      Medical Dialogues Bureau25 Oct 2019 9:17 AM IST
      Late Thursday, CNBC reported that Walmart, the world's largest retailer, had also removed and blocked all of the recalled Johnson's baby powder (JnJ...
      Reckitt Benckiser to pay USD 700 million to settle opioid probes

      Reckitt Benckiser to pay USD 700 million to settle opioid probes

      Medical Dialogues Bureau25 Oct 2019 9:15 AM IST
      Reckitt Benckiser in July agreed to pay up to $1.4 billion to resolve the U.S. claims that its former pharmaceuticals business Indivior before it was...
      GSK ovarian cancer drug Zejula gets USFDA nod for wider use

      GSK ovarian cancer drug Zejula gets USFDA nod for wider use

      Medical Dialogues Bureau24 Oct 2019 10:00 AM IST
      Zejula was the lead compound of U.S. cancer specialist Tesaro, which GSK acquired for $5.1 billion last year. Zejula brought in sales of 57 million...
      Strides Pharma clears USFDA inspection of Alathur facility

      Strides Pharma clears USFDA inspection of Alathur facility

      Medical Dialogues Bureau24 Oct 2019 9:45 AM IST
      Strides Pharma said in a filing, the company's formulations unit in Alathur was inspected by the US Food and Drug Administration (USFDA) in August...
      Dr Reddys recalls Ranitidine products in US over cancer-causing impurity

      Dr Reddys recalls Ranitidine products in US over cancer-causing impurity

      Medical Dialogues Bureau24 Oct 2019 9:30 AM IST
      This recall follows the USFDA's caution note alerting patients and healthcare professionals that NDMA was found in certain samples of ranitidine, Dr...
      No carcinogen found in alternatives of heart burn drug Zantac, generics: USFDA

      No carcinogen found in alternatives of heart burn drug Zantac, generics: USFDA

      Medical Dialogues Bureau24 Oct 2019 9:20 AM IST
      Early tests of alternatives to over-the-counter ranitidine, such as Pepcid, Tagamet, Nexium, Prevacid and Prilosec show no NDMA, the agency said.New...
      Single-member NCLT bench to give finality to split verdict over Unimark Remedies resolution

      Single-member NCLT bench to give finality to split verdict over Unimark Remedies resolution

      Medical Dialogues Bureau24 Oct 2019 9:00 AM IST
      The NCLT had initiated Corporate Insolvency Resolution Process against Unimark Remedies on Apri 13, 2018 admitting the plea of the private sector...
      DCGI nod to Lincoln pharma Diclofenac Rectal Spray for reducing types of pain

      DCGI nod to Lincoln pharma Diclofenac Rectal Spray for reducing types of pain

      Medical Dialogues Bureau23 Oct 2019 4:24 PM IST
      The patent has been awarded by the Government of India for "a novel liquid rectal spray dosage form containing diclofenac and its pharmaceutically...
      J&J CEO testified Baby Powder was safe 13 days before FDA bombshell

      J&J CEO testified Baby Powder was safe 13 days before FDA bombshell

      Medical Dialogues Bureau23 Oct 2019 1:21 PM IST
      "There were in fact differences between cornstarch and talc-based baby powder in its feel, in its absorbency," said Gorsky, who has been J&J's CEO...
      Syngene reports robust 11% YOY revenue growth in Q2 FY20

      Syngene reports robust 11% YOY revenue growth in Q2 FY20

      Medical Dialogues Bureau23 Oct 2019 12:18 PM IST
      Bengaluru: Syngene International Limited recently announced its Q2 FY20 results posting quarterly revenue of Rs. 485 Cr, an increase of 11% from the...
      Lupin gets USFDA nod for generic equivalent of Depakote ER Tablets to treat epilepsy in US

      Lupin gets USFDA nod for generic equivalent of Depakote ER Tablets to treat epilepsy in US

      Medical Dialogues Bureau23 Oct 2019 11:38 AM IST
      "The United States Food and Drug Administration (U.S. FDA), to market a generic equivalent of Depakote Extended-Release Tablets, 250 mg and 500 mg, of...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok